Alendronate improves QOL of postmenopausal women with osteoporosis.

Clinical interventions in aging

Volumn 5, Issue , 2010, Pages 123-131

  Kawate, Hisaya ^a   Ohnaka, Keizo ^b   Adachi, Masahiro ^b   Kono, Suminori ^b   Ikematsu, Hideyuki ^b   Matsuo, Hisashi ^b   Higuchi, Kazumi ^b   Takayama, Takehiko ^b   Takayanagi, Ryoichi ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BONE DENSITY CONSERVATION AGENT;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; JAPAN; MIDDLE AGED; POSTMENOPAUSE OSTEOPOROSIS; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; ALENDRONATE; BONE DENSITY CONSERVATION AGENTS; FEMALE; HUMANS; JAPAN; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 77955297766     PISSN: None     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/cia.s9696     Document Type: Article

References (0)